205 related articles for article (PubMed ID: 10531239)
1. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
Jiang C; Magee DM; Cox RA
Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
[TBL] [Abstract][Full Text] [Related]
2. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
Jiang C; Magee DM; Ivey FD; Cox RA
Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
[TBL] [Abstract][Full Text] [Related]
3. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
4. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice.
Peng T; Shubitz L; Simons J; Perrill R; Orsborn KI; Galgiani JN
Infect Immun; 2002 Jul; 70(7):3330-5. PubMed ID: 12065470
[TBL] [Abstract][Full Text] [Related]
5. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen.
Abuodeh RO; Shubitz LF; Siegel E; Snyder S; Peng T; Orsborn KI; Brummer E; Stevens DA; Galgiani JN
Infect Immun; 1999 Jun; 67(6):2935-40. PubMed ID: 10338502
[TBL] [Abstract][Full Text] [Related]
6. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
[TBL] [Abstract][Full Text] [Related]
7. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
8. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
9. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
Awasthi S; Vilekar P; Conkleton A; Rahman N
Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
[TBL] [Abstract][Full Text] [Related]
11. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis.
Jiang C; Magee DM; Cox RA
Infect Immun; 1999 Jun; 67(6):2996-3001. PubMed ID: 10338510
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.
Zhu Y; Yang C; Magee DM; Cox RA
Infect Immun; 1996 Jul; 64(7):2695-9. PubMed ID: 8698497
[TBL] [Abstract][Full Text] [Related]
13. Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis.
Silva AJ; Mohan A; Benitez JA
Vaccine; 2003 Dec; 21(32):4715-21. PubMed ID: 14585681
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
15. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
17. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Vilekar P; Awasthi V; Lagisetty P; King C; Shankar N; Awasthi S
BMC Immunol; 2010 Dec; 11():60. PubMed ID: 21143974
[TBL] [Abstract][Full Text] [Related]
18. Identification of a protective antigen of Coccidioides immitis by expression library immunization.
Ivey FD; Magee DM; Woitaske MD; Johnston SA; Cox RA
Vaccine; 2003 Oct; 21(27-30):4359-67. PubMed ID: 14505918
[TBL] [Abstract][Full Text] [Related]
19. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
20. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.
Yamakami K; Akao S; Sato M; Nitta Y; Miyazaki J; Tadakuma T
Parasitol Int; 2001 Jul; 50(2):81-91. PubMed ID: 11438430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]